METACRINE INVESTOR ALERT by the Former Attorney General of Louisiana

Kahn Swick & Foti, LLC Investigates Merger of Metacrine Inc. - MTCR

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Metacrine Inc. (NasdaqCM: MTCR) (the “Company”) with Equillium, Inc. (NasdaqGM: EQ) in an all-stock transaction. KSF is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger undervalues the Company.

If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn ([e-mail]) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nasdaqcm-mtcr/ to learn more.

To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com.

Kahn Swick & Foti, LLC
1100 Poydras St., Suite 3200
New Orleans, LA 70163

View source version on businesswire.com: https://www.businesswire.com/news/home/20221004005889/en/

The Metacrine Stock at the time of publication of the news with a raise of +2,27 % to 0,50USD on Nasdaq stock exchange (04. Oktober 2022, 16:12 Uhr).